Why FDA Guardrails Still Matter in a Fast-Moving MedTech Industry with Suzanne Levy Friedman, Partner at Honigman
As AI and software become embedded in more medical technologies, companies must balance the pressure to innovate quickly with the responsibility to protect patients.
In this episode, Suzanne Levy Friedman, Partner at Honigman, discusses how medical device and digital health companies can navigate evolving FDA regulations and bring products to market more efficiently. She explains how regulatory counsel helps organizations determine whether products fall under FDA oversight, distinguish wellness technologies from regulated devices, and build effective commercialization strategies. Suzanne also…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.